Se connecter
Intranet
Thème

Biographie pas encore disponible.

Publications

2023
Dumond Bourie A, Potier JB, Pinget M, Bouzakri K, Myokines: Crosstalk and Consequences on Liver Physiopathology., Nutrients 2023 Mar; 15(7): .
2022
Langlois A, Dumond A, Vion J, Pinget M, Bouzakri K, Crosstalk Communications Between Islets Cells and Insulin Target Tissue: The Hidden Face of Iceberg., Front Endocrinol (Lausanne) 2022 ; 13(): 836344.
2022
Yepmo M, Potier JB, Pinget M, Grabarz A, Bouzakri K, Dumond Bourie A, Discussing the role of circular RNA in the pathogenesis of non-alcoholic fatty liver disease and its complications., Front Endocrinol (Lausanne) 2022 ; 13(): 1035159.
2021
Dumond A, Montemagno C, Vial V, Grépin R, Pagès G, Anti-Vascular Endothelial Growth Factor C Antibodies Efficiently Inhibit the Growth of Experimental Clear Cell Renal Cell Carcinomas., Cells 2021 May; 10(5): .
2021
Dumond A, Brachet E, Durivault J, Vial V, Puszko AK, Lepelletier Y, Montemagno C, Pagnuzzi-Boncompagni M, Hermine O, Garbay C, Lagarde N, Montes M, Demange L, Grépin R, Pagès G, Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma., J Exp Clin Cancer Res 2021 Jan; 40(1): 33.
2020
2020
Dumond A, Demange L, Pagès G, [Neuropilins: relevant therapeutic targets to improve the treatment of cancers]., Med Sci (Paris) 2020 May; 36(5): 487-496.
2020
Grépin R, Guyot M, Dumond A, Durivault J, Ambrosetti D, Roussel JF, Dupré F, Quintens H, Pagès G, The combination of bevacizumab/Avastin and erlotinib/Tarceva is relevant for the treatment of metastatic renal cell carcinoma: the role of a synonymous mutation of the EGFR receptor., Theranostics 2020 ; 10(3): 1107-1121.
2020
Dumond A, Pagès G, Neuropilins, as Relevant Oncology Target: Their Role in the Tumoral Microenvironment., Front Cell Dev Biol 2020 ; 8(): 662.
2019
Brachet E, Dumond A, Liu WQ, Fabre M, Selkti M, Raynaud F, Hermine O, Benhida R, Belmont P, Garbay C, Lepelletier Y, Ronco C, Pagès G, Demange L, Synthesis, 3D-structure and stability analyses of NRPa-308, a new promising anti-cancer agent., Bioorg Med Chem Lett 2019 Dec; 29(24): 126710.